Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Convatec Group Plc (CTEC.LN)

Convatec Group Plc (CTEC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Convatec Group Plc 20 Eastbourne Terrace 7th Floor London W2 6LG GBR

https://www.convatecgroup.com P: 782-644-7807

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.

Key Statistics

Overview:

Market Capitalization, $K 4,483,637
Shares Outstanding, K 1,949,407
% of Insider Shareholders 0.95%
% of Institutional Shareholders 50.89%

Financials:

Annual Sales, $ 2,289 M
Annual Net Income, $ 190,500 K

Growth:

1-Year Return -7.78%
3-Year Return -4.96%
5-Year Return 13.64%
5-Year Revenue Growth 4.61%
5-Year Earnings Growth 79.43%
5-Year Dividend Growth 1.79%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 0.11
EPS Growth vs. Prev Year 0.48%
Annual Dividend & Yield (Paid) 0.07 (2.19%)
Annual Dividend & Yield (Fwd) 0.03 (2.19%)
Most Recent Dividend 0.014 on 08/21/25
Next Ex-Dividends Date 08/21/25
Dividend Payable Date 10/01/25
Dividend Payout Ratio 63.65%

CTEC.LN Ratios

Ratio
Price/Earnings ttm 29.99
Price/Earnings forward 15.60
Return-on-Equity % 12.50%
Return-on-Assets % 5.86%
Profit Margin % 8.32%
Debt/Equity 0.70
Price/Sales 2.77
Price/Book 3.42
Book Value/Share 0.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar